BindingDB logo
myBDB logout

23 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28197315 10 Affinity-Based Selectivity Profiling of an In-Class Selective Competitive Inhibitor of Acyl Protein Thioesterase 2.EBI University of Michigan
28280261 84 Non-kinase targets of protein kinase inhibitors.EBI The University of Sydney
26854376 31 Non-symmetrical furan-amidines as novel leads for the treatment of cancer and malaria.EBI University of Manchester
23953689 37 Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.EBI Purdue University
18400335 39 A novel quantitative structure-activity relationship method to predict the affinities of MT3 melatonin binding site.EBI Lanzhou University
22494098 8 Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2).EBI caprotec bioanalytics GmbH
23131339 6 Synthesis of novel¿¿3 receptor ligands via an unusual Knoevenagel condensation.EBI Moscow State University
20684563 176 Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.EBI H. Lundbeck A/S
20558073 28 Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.EBI Purdue University
22206487 17 Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2.EBI Purdue University
21859103 21 Novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2): crystal structures, biochemical activity, and intracellular effects of imidazoacridin-6-ones.EBI University of Manchester
21105712 25 Potential chemopreventive agents based on the structure of the lead compound 2-bromo-1-hydroxyphenazine, isolated from Streptomyces species, strain CNS284.EBI Purdue University
21377769 30 Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.EBI Univ Lille Nord de France
21261296 6 Bioactive compounds from the fern Lepisorus contortus.EBI Yunnan Normal University
21074425 44 In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).EBI University of Manchester and Manchester Cancer Research Center
20356739 18 Imidazoacridin-6-ones as novel inhibitors of the quinone oxidoreductase NQO2.EBI the University of Manchester and Manchester Cancer Research Center
20036559 31 Triazoloacridin-6-ones as novel inhibitors of the quinone oxidoreductases NQO1 and NQO2.EBI University of Manchester and Manchester Cancer Research Center
12213062 70 Synthesis of a novel series of benzocycloalkene derivatives as melatonin receptor agonists.EBI Takeda Chemical Industries, Ltd.
11960497 36 Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).EBI Institut de Chimie Pharmaceutique Albert Lespagnol
25379648 6 Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.BDB University of Western Ontario
21718050 9 Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems.BDB University of Colorado Denver
18254726 8 Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2.BDB University of Illinois at Chicago
19265439 43 Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities.BDB Purdue University